Calspan Awarded DARPA Air Combat Evolution (ACE) Contract
08 juil. 2020 10h04 HE
|
Calspan
Buffalo, New York, July 08, 2020 (GLOBE NEWSWIRE) -- Calspan Corporation has been awarded a $14.1M, four-year contract by the Defense Advanced Research Projects Agency (DARPA) to develop full-scale...
Aviatrix Unveils CoPilot for Enterprise-Class Operational Visibility of Multi-Cloud Networks
21 avr. 2020 09h02 HE
|
Aviatrix
SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- Aviatrix, the cloud network platform, today announced CoPilot to provide enterprises with advanced operational visibility and troubleshooting...
Autonomous Technology Industry Leader, EasyMile, Standardizes Global Cloud Infrastructure Using Aviatrix Cloud Networking Software
26 févr. 2020 09h00 HE
|
Aviatrix
SANTA CLARA, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Aviatrix, the leading provider of cloud networking software for the multi-cloud enterprise, today announced that EasyMile, a global leader in...
Aviatrix Announces ALTITUDE 2020 – Above the Clouds™ Multi-Cloud Networking Industry Event
25 févr. 2020 09h02 HE
|
Aviatrix
March 3rd Event in Santa Clara Hosted by theCUBE and Also Livestreamed Best Practices and Real-World Experiences from IT Execs and Systems Integrators Architecting Networks that Rise Above AWS,...
Nearmap Brings Precise Roof Geometry Measurement to Your Fingertips Through API Integration
04 févr. 2020 09h00 HE
|
Nearmap
DALLAS, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Nearmap, a company that delivers high-resolution aerial imagery as a service to businesses across the world, announced today the coming of a new roof...
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
13 août 2019 16h35 HE
|
DiaMedica Therapeutics Inc.
Phase Ib study of DM199 in Chronic Kidney Disease enrollment completeEncouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II...
DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
12 août 2019 08h00 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that Rick Pauls, President and CEO, will be presenting at the 2019 Intellisight Conference,...
DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
08 août 2019 16h00 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its second quarter 2019 financial results will be released after the markets close on...
DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting
30 avr. 2019 16h58 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, April 30, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that Dr Harry Alcorn, its Chief Medical Officer...
DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
14 févr. 2019 08h00 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that it has initiated dosing patients with chronic...